Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?

Introduction: The use of lifelong antiretroviral therapy (ART) results in increased costs of care; the ability to finance and control sustained costs of ART needs to be discussed. Approach: The Southern Alberta Clinic initiated a practical cost savings approach that switched select patients from a b...

Full description

Bibliographic Details
Main Authors: Hartmut Krentz PhD, Shayna Campbell BSc, John Gill MD
Format: Article
Language:English
Published: SAGE Publishing 2019-01-01
Series:Journal of the International Association of Providers of AIDS Care
Online Access:https://doi.org/10.1177/2325958218822304
_version_ 1818317348963090432
author Hartmut Krentz PhD
Shayna Campbell BSc
John Gill MD
author_facet Hartmut Krentz PhD
Shayna Campbell BSc
John Gill MD
author_sort Hartmut Krentz PhD
collection DOAJ
description Introduction: The use of lifelong antiretroviral therapy (ART) results in increased costs of care; the ability to finance and control sustained costs of ART needs to be discussed. Approach: The Southern Alberta Clinic initiated a practical cost savings approach that switched select patients from a branded ART to a less expensive generic variation. Our approach surveyed physicians and patients on their acceptance of switching and then launched a program asking patients if they would switch to generic variations for cost control purposes. Results: Our early findings found >50% of patients approached agreed to switch. We found no evidence of increased risk of viral breakthrough, resistance, side effects, or displeasure with generic drugs. Measured cost savings in the first year were >$1.1 million with annual projected savings of between $4.3 million and $2.6 million (in 2017 Cdn$). Conclusion: Our approach can provide an option for controlling costs of HIV care without compromising quality.
first_indexed 2024-12-13T09:35:54Z
format Article
id doaj.art-3f0db9995d7748cb803e477963b06b75
institution Directory Open Access Journal
issn 2325-9582
language English
last_indexed 2024-12-13T09:35:54Z
publishDate 2019-01-01
publisher SAGE Publishing
record_format Article
series Journal of the International Association of Providers of AIDS Care
spelling doaj.art-3f0db9995d7748cb803e477963b06b752022-12-21T23:52:21ZengSAGE PublishingJournal of the International Association of Providers of AIDS Care2325-95822019-01-011810.1177/2325958218822304Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?Hartmut Krentz PhD0Shayna Campbell BSc1John Gill MD2 Department of Medicine, University of Calgary, Calgary, Canada Southern Alberta Clinic, Calgary, Canada Department of Medicine, University of Calgary, Calgary, CanadaIntroduction: The use of lifelong antiretroviral therapy (ART) results in increased costs of care; the ability to finance and control sustained costs of ART needs to be discussed. Approach: The Southern Alberta Clinic initiated a practical cost savings approach that switched select patients from a branded ART to a less expensive generic variation. Our approach surveyed physicians and patients on their acceptance of switching and then launched a program asking patients if they would switch to generic variations for cost control purposes. Results: Our early findings found >50% of patients approached agreed to switch. We found no evidence of increased risk of viral breakthrough, resistance, side effects, or displeasure with generic drugs. Measured cost savings in the first year were >$1.1 million with annual projected savings of between $4.3 million and $2.6 million (in 2017 Cdn$). Conclusion: Our approach can provide an option for controlling costs of HIV care without compromising quality.https://doi.org/10.1177/2325958218822304
spellingShingle Hartmut Krentz PhD
Shayna Campbell BSc
John Gill MD
Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?
Journal of the International Association of Providers of AIDS Care
title Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?
title_full Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?
title_fullStr Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?
title_full_unstemmed Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?
title_short Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?
title_sort desimplification of single tablet antiretroviral art regimens a practical cost savings strategy
url https://doi.org/10.1177/2325958218822304
work_keys_str_mv AT hartmutkrentzphd desimplificationofsingletabletantiretroviralartregimensapracticalcostsavingsstrategy
AT shaynacampbellbsc desimplificationofsingletabletantiretroviralartregimensapracticalcostsavingsstrategy
AT johngillmd desimplificationofsingletabletantiretroviralartregimensapracticalcostsavingsstrategy